{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-001770","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.000863+00:00","generated_at":"2026-05-24T17:52:51.250076+00:00","sec_items":["1.01","2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cyclacel acquires Plogosertib assets from liquidated subsidiary for £250K","bullets":["Cyclacel Pharmaceuticals buys PLK1 inhibitor Plogosertib assets from wholly-owned UK subsidiary in liquidation for £250,000.","Includes patent rights, API, CMC data, preclinical and clinical data, and know-how related to Plogosertib.","Buyer agrees to only sell assets for cash consideration within 24 months; any surplus (50% of net proceeds) paid to subsidiary.","Transaction closed on March 10, 2025; Patent Assignment Agreement also executed.","Debt/liabilities of seller not assumed; buyer responsible for subsequent disposal surplus payments."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-001770","json":"https://secwatch.observer/filing/0001829126-25-001770.json","markdown":"https://secwatch.observer/filing/0001829126-25-001770.md","text":"https://secwatch.observer/filing/0001829126-25-001770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000182912625001770/0001829126-25-001770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000182912625001770/cyclacel_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T17:52:51.250076+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}